SCHEMBL2875198

SCHEMBL2875198

C=CC(C#N)=C(C#N)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2875196 1.00 LMNA (0.35) LMNA
SCHEMBL11061361 0.74 ALDH1A1 (0.38) LMNA
SCHEMBL17109663 0.73 ALDH1A1 (0.38)
SCHEMBL7195077 0.73 ALDH1A1 (0.32) LMNA
SCHEMBL7195083 0.73 ALDH1A1 (0.32) LMNA
SCHEMBL9171301 0.70 ALDH1A1 (0.38)
SCHEMBL7911515 0.70
SCHEMBL9508911 0.70 AKT1 (0.38) LMNA
SCHEMBL16027145 0.68
SCHEMBL6293725 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927071-B2 Process for preparing electron deficient olefins Henkel IP & Holding GmbH (DE) 2021-02-23 US claimed
EP-3558934-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS Henkel IP & Holding GmbH (DE) 2019-10-30 EP claimed
US-20190292141-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS HENKEL AG & CO. KGAA (DE) 2019-09-26 US claimed
WO-2018114458-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS Henkel IP & Holding GmbH (DE) 2018-06-28 WO claimed
US-7718821-B1 Method of preparing electron deficient olefins LOCTITE (R&D) LIMITED (IL) 2010-05-18 US claimed
US-7659423-B1 Method of preparing electron deficient olefins in polar solvents LOCTITE (R&D) LIMITED (IE) 2010-02-09 US claimed
US-7569719-B1 Method of preparing electron deficient olefins LOCTITE (R&D) LIMITED (IE) 2009-08-04 US claimed
EP-3558934-B1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS HENKEL AG & CO KGAA (DE) 2025-04-30 EP disclosed
US-10927071-B2 Process for preparing electron deficient olefins Henkel IP & Holding GmbH (DE) 2021-02-23 US disclosed
EP-3558934-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS Henkel IP & Holding GmbH (DE) 2019-10-30 EP disclosed
US-20190292141-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS HENKEL AG & CO. KGAA (DE) 2019-09-26 US disclosed
WO-2018114458-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS Henkel IP & Holding GmbH (DE) 2018-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292141-A1 PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS PCCA, COASY, LIG4 LMNA 2757/4885
US-10927071-B2 Process for preparing electron deficient olefins PCCA, COASY, LIG4 LMNA 2757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.